Search research articles
Contact Us
Filters
Showing results (41-50 of 76) with videos related to
Page
of 8
Sort By:
Journal of Pharmaceutical and Biomedical Analysis
|
May 15, 2002
Stability of 5-acetamido-6-formylamino-3-methyluracil in buffers and urine
Pierre Wong, Gérald Villeneuve, Vicky Tessier, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 18, 2002
Inhibition of epidermal growth factor receptor-mediated signaling by "Combi-triazene" BJ2000, a new probe for Combi-Targeting postulates
Fouad Brahimi, Stephanie L Matheson, Fabienne Dudouit, et al.
Cancer Chemotherapy and Pharmacology
|
December 24, 2002
The combi-targeting concept: a novel 3,3-disubstituted nitrosourea with EGFR tyrosine kinase inhibitory properties
Qiyu Qiu, Fabienne Dudouit, Stephanie L Matheson, et al.
Journal of Vascular Surgery
|
November 1, 1994
Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall
K M Newman, J Jean-Claude, H Li, et al.
International Journal of Molecular Sciences
|
September 10, 2021
Quantitative Analysis of the Potency of Equimolar Two-Drug Combinations and Combi-Molecules Involving Kinase Inhibitors In Vitro: The Concept of Balanced Targeting
Suman Rao, Benoît Thibault, Lisa Peyrard, et al.
Chemical Biology & Drug Design
|
March 8, 2008
Synthesis of water soluble bis-triazenoquinazolines: an unusual predicted mode of binding to the epidermal growth factor receptor tyrosine kinase
Anne-Laure Larroque, Brad Peori, Christopher Williams, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
July 19, 2011
A bioanalytical investigation on the exquisitely strong in vitro potency of the EGFR-DNA targeting type II combi-molecule ZR2003 and its mitigated in vivo antitumour activity
Nahid Golabi, Fouad Brahimi, Ying Huang, et al.
Biochemical Pharmacology
|
June 29, 2005
Mechanism of action of a novel "combi-triazene" engineered to possess a polar functional group on the alkylating moiety: evidence for enhancement of potency
Fouad Brahimi, Zakaria Rachid, James P McNamee, et al.
Plos One
|
February 7, 2015
Target modulation by a kinase inhibitor engineered to induce a tandem blockade of the epidermal growth factor receptor (EGFR) and c-Src: the concept of type III combi-targeting
Suman Rao, Anne-Laure Larroque-Lombard, Lisa Peyrard, et al.
Molecules (Basel, Switzerland)
|
July 30, 2017
<sup>15</sup>N-, <sup>13</sup>C- and ¹H-NMR Spectroscopy Characterization and Growth Inhibitory Potency of a Combi-Molecule Synthesized by Acetylation of an Unstable Monoalkyltriazene
Zhor Senhaji Mouhri, Elliot Goodfellow, Steven P Kelley, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 76) with videos related to
Sort By:
Page
of 8
Journal of Pharmaceutical and Biomedical Analysis
|
May 15, 2002
Stability of 5-acetamido-6-formylamino-3-methyluracil in buffers and urine
Pierre Wong, Gérald Villeneuve, Vicky Tessier, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 18, 2002
Inhibition of epidermal growth factor receptor-mediated signaling by "Combi-triazene" BJ2000, a new probe for Combi-Targeting postulates
Fouad Brahimi, Stephanie L Matheson, Fabienne Dudouit, et al.
Cancer Chemotherapy and Pharmacology
|
December 24, 2002
The combi-targeting concept: a novel 3,3-disubstituted nitrosourea with EGFR tyrosine kinase inhibitory properties
Qiyu Qiu, Fabienne Dudouit, Stephanie L Matheson, et al.
Journal of Vascular Surgery
|
November 1, 1994
Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall
K M Newman, J Jean-Claude, H Li, et al.
International Journal of Molecular Sciences
|
September 10, 2021
Quantitative Analysis of the Potency of Equimolar Two-Drug Combinations and Combi-Molecules Involving Kinase Inhibitors In Vitro: The Concept of Balanced Targeting
Suman Rao, Benoît Thibault, Lisa Peyrard, et al.
Chemical Biology & Drug Design
|
March 8, 2008
Synthesis of water soluble bis-triazenoquinazolines: an unusual predicted mode of binding to the epidermal growth factor receptor tyrosine kinase
Anne-Laure Larroque, Brad Peori, Christopher Williams, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
July 19, 2011
A bioanalytical investigation on the exquisitely strong in vitro potency of the EGFR-DNA targeting type II combi-molecule ZR2003 and its mitigated in vivo antitumour activity
Nahid Golabi, Fouad Brahimi, Ying Huang, et al.
Biochemical Pharmacology
|
June 29, 2005
Mechanism of action of a novel "combi-triazene" engineered to possess a polar functional group on the alkylating moiety: evidence for enhancement of potency
Fouad Brahimi, Zakaria Rachid, James P McNamee, et al.
Plos One
|
February 7, 2015
Target modulation by a kinase inhibitor engineered to induce a tandem blockade of the epidermal growth factor receptor (EGFR) and c-Src: the concept of type III combi-targeting
Suman Rao, Anne-Laure Larroque-Lombard, Lisa Peyrard, et al.
Molecules (Basel, Switzerland)
|
July 30, 2017
<sup>15</sup>N-, <sup>13</sup>C- and ¹H-NMR Spectroscopy Characterization and Growth Inhibitory Potency of a Combi-Molecule Synthesized by Acetylation of an Unstable Monoalkyltriazene
Zhor Senhaji Mouhri, Elliot Goodfellow, Steven P Kelley, et al.
Page
of 8